申请人:Université de Franche-Comté
公开号:EP3929186A1
公开(公告)日:2021-12-29
The present invention relates to compounds of formula (I) as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the present disclosure, and their use as a medicament, in particular for the treatment of neurodegenerative diseases.
本发明涉及式(I)的化合物以及其药用可接受的盐,其中取代基如本公开披露的那样,并且它们作为药物的用途,特别是用于治疗神经退行性疾病。